| Literature DB >> 31953513 |
Mengxia Yu1,2, Chenying Li1,3, Chao Hu1,3, Jingrui Jin1,3, Shenxian Qian2, Jie Jin4,5.
Abstract
Epidemiologic studies of the relationship between nitrite or nitrate consumption and risk of non-Hodgkin lymphoma (NHL) remain controversial. The current meta-analysis aimed to reexamine the evidence and quantitatively evaluate that relationship. Manuscripts were retrieved from the Web of Science, Chinese National Knowledge Infrastructure and PubMed databases up to May 2019. From the studies included in the review, results were combined and presented as odds ratios (OR). To conduct a dose-response (DR) analysis, studies presenting risk estimates over a series of categories of exposure were selected. Our data indicate that the consumption of nitrite was linked to a significantly increased hazard of NHL (OR: 1.37; 95% CI: 1.14-1.65), rather than nitrate (OR: 1.02; 95% CI: 0.94-1.10). According to Egger's and Begg's tests (P > 0.05), there was no evidence of significant publication bias. Moreover, our DR analysis indicated that the risk of NHL grew by 26% for each additional microgram of nitrite consumed in the diet per day (OR: 1.26; 95% CI: 1.09-1.42). Through subset analysis of the nitrite studies, data from the high-quality studies indicated that consumption was positively associated with carcinogenicity, leading to NHL (OR: 1.44; 95% CI: 1.17-1.77) and positively correlated with the development of diffuse large B-cell lymphoma (OR: 1.55; 95% CI: 1.07-2.26), but not other NHL subtypes. In addition, the data suggested that females (OR: 1.50; 95% CI: 1.15-1.95) and high levels of nitrite intake (OR: 1.64; 95% CI: 1.28-2.09) had a higher risk of NHL. Our meta-analysis supports the hypothesis that nitrite intake, but not that of nitrate, raises the risk of developing NHL. In the future, better designed prospective research studies should be conducted to confirm our findings, clarify potential biological mechanisms and instruct clinicians about NHL prophylaxis.Entities:
Mesh:
Substances:
Year: 2020 PMID: 31953513 PMCID: PMC6969097 DOI: 10.1038/s41598-020-57453-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart describing the selection of studies included in the meta-analysis.
Principal characteristics of studies evaluating the association between nitrate or nitrite and risk of NHL.
| Study | year | Country | Gender | Age | Study | Source | Number | Number | Items | Source of nitrate | Study | Matching and Adjustments |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ward | 1996 | United States | M/F | ≥21 | Case-control | Population-based | 156 | 527 | Nitrate | Dieta and drinking waterb | 8 | Race, gender, vital status, family history of cancer, vitamin C, carotenes, education, smoking and age |
| Ward | 2006 | United States | M/F | 20–74 | Case-control | Population-based | 1321 | 1057 | Nitrate and nitrite | Diet and drinking water | 7 | Age, gender, center, race, education, caloric intake, study matching factors and gender |
| Aschebrook-Kilfoy | 2010 | United States | F | 21–84 | Case-control | Population-based | 594 | 710 | Nitrate and nitrite | Diet | 7 | Age, family history of NHL, total daily energy intake, vitamin C intake, vitamin E intake, smoking and protein intake |
| Chiu | 2008 | United States | M/F | ≥21 | Case-control | Population-based | 147 | 1075 | Nitrate and nitrite | Diet | 8 | Age, sex, type of respondent, family history of cancer, and body mass index |
| Cocco | 2003 | Italy | M/F | ≥10 | Follow-up study | Population-based | 737 | NR | Nitrate | Drinking water | 5 | Gender, age, and population size |
| Law | 1999 | United Kingdom | NR | 0–79 | Follow-up study | Population-based | 2673 | NR | Nitrate | Drinking water | 4 | Age, gender and population density |
| Freedman | 2000 | United States | M | ≥30 | Case-control | Population-based | 73 | 147 | Nitrate | Drinking water | 6 | Age |
| Gulis | 2002 | Slovak Republic | M/F | ≥20 | Follow-up study | Population-based | 41 | NR | Nitrate | Drinking water | 5 | NR |
| Aschebrook-Kilfoy | 2013 | United States | M/F | 20–75 | Case-control | Population-based | 335 | 469 | Nitrate and nitrite | Diet | 5 | Sex, age, body mass index, education, family history of cancer, vitamin C and E intake, smoking, and total daily caloric intake |
| Chang | 2010 | China | M/F | 50–69 | Case-control | Population-based | 1716 | 1716 | Nitrate | Drinking water | 5 | NR |
| Rhoades | 2013 | United States | M/F | 54–76 | Case-control | Population-based | 140 | 192 | Nitrate | Drinking water | 5 | Age, BMI, smoking, education, family history of cancer, drinking water contaminants and sex |
| Weyer | 2001 | United States | F | 55–69 | Follow-up study | Population-based | 134 | 21977 | Nitrate | Diet and drinking water | 7 | Age, vitamin C and E intake, physical activity, education, smoking, water source, total energy, dietary nitrate, fruits and vegetables, body mass index and waist-to-hip ratio |
Abbreviations: M, male; F, female; NR, not reported; NHL, non-Hodgkin lymphoma; BMI, body mass index. aDiet: details were assessed from food frequency questionnaire. bDrinking water: details were assessed from official measurements.
Figure 2Forest plots illustrating risk estimates from studies included in the review on the relationships between nitrite (A) or nitrate intake (B) and the risk of NHL. The size of gray box is positively proportional to the weight assigned to each study, and horizontal lines represent the 95% confidence intervals.
Figure 3Funnel plots of: (A) nitrite or (B) nitrate intake (B) for risk of NHL.
Figure 4The trim-and-fill test did not identify possible missing studies for: (A) nitrite or (B) nitrate.
Subgroup analyses of odds ratios for the relationship between nitrite intake and risk of NHL.
| Variables | Number of studies | OR (95% CI) | Q-test for heterogeneity | |
|---|---|---|---|---|
| Total | 4 | 1.37 (1.14–1.65) | 0.083 (55.0%) | |
| Gender | 0.290 | |||
| male | 1 | 0.84 (0.52–1.36) | — | |
| female | 2 | 1.50 (1.15–1.95) | 0.608 (0.0%) | |
| Study quality | 0.605 | |||
| High | 3 | 1.44 (1.17–1.77) | 0.057 (65.2%) | |
| Low | 1 | 1.16 (0.78–1.72) | — | |
| NHL subtype | 0.800 | |||
| DLBCL | 2 | 1. 55 (1.07–2.26) | 0.085 (66.3%) | |
| FL | 2 | 1.29 (0.89–1.86) | 0.045 (75.1%) | |
| Study design | — | |||
| Case-control study | 4 | 1.37 (1.14–1.65) | 0.083 (55.0%) | |
| Geographical area | — | |||
| United States | 4 | 1.37 (1.14–1.65) | 0.083 (55.0%) | |
| Source of nitrite | — | |||
| Diet | 4 | 1.37 (1.14–1.65) | 0.083 (55.0%) | |
| Levels in diet | 0.170 | |||
| High | 2 | 1.64 (1.28–2.09) | 0.186 (42.9%) | |
| Low | 2 | 1.08 (0.82–1.44) | 0.635 (0.0%) |
Abbreviations: NHL, non-Hodgkin lymphoma; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma.
Subgroup analyses of odds ratios for the relationship between nitrate intake and risk of NHL.
| Variables | Number of studies | OR (95% CI) | Q-test for heterogeneity | |
|---|---|---|---|---|
| Total | 11 | 1.02 (0.94–1.10) | 0.308 (14.2%) | |
| Gender | 0.767 | |||
| male | 5 | 1.03 (0.61–1.46) | 0.333 (12.6%) | |
| female | 6 | 1.00 (0.76–1.24) | 0.722 (0.0%) | |
| Study quality | 0.188 | |||
| High | 4 | 0.85 (0.66–1.04) | 0.751 (0.0%) | |
| Low | 7 | 1.00 (0.91–1.09) | 0.015 (62.0%) | |
| NHL subtype | 0.462 | |||
| DLBCL | 2 | 0.86 (0.61–1.23) | 0.334 (0.0%) | |
| FL | 2 | 1.14 (0.80–1.63) | 0.141 (53.8%) | |
| Study design | 0.988 | |||
| Case-control study | 7 | 0.90 (0.77–1.02) | 0.028 (57.6%) | |
| Follow-up study | 4 | 1.03 (0.93–1.14) | 0.589 (0.0%) | |
| Geographical area | 0.119 | |||
| North America | 7 | 0.77 (0.62–0.92) | 0.272 (20.6%) | |
| Europe | 3 | 1.05 (0.94–1.16) | 0.505 (0.0%) | |
| China | 1 | 1.08 (0.90–1.26) | — | |
| Source of nitrate | 0.080 | |||
| Diet | 5 | 0.83 (0.68–1.01) | 0.028 (63.1%) | |
| Water | 9 | 0.96 (0.78–1.14) | 0.019 (56.4%) | |
| Levels in the water | 0.599 | |||
| High | 3 | 1.05 (0.94–1.16) | 0.505 (0.0%) | |
| Low | 3 | 0.78 (0.30–1.26) | 0.002 (83.6%) |
Abbreviations: NHL, non-Hodgkin lymphoma; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; NR, not reported.
Figure 5Odds ratio for NHL against dose of nitrite intake based on the results of the dose-response meta-analysis. Solid line represents estimated odds ratios, while the dotted lines represent 95% confidence intervals.
Figure 6Galbraith plot analysis used to evaluate heterogeneity for: (A) nitrite and (B) nitrate studies.